Medium materiality6/10
ResMed price target lowered to $255 from $260 at KeyBanc
Why it may matterVerify against the original reporting
Upside remains as target above current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RMD target lowered to $255; posted price $223.24.
- KeyBanc: RMD target $255; price $223.24
Key facts
- 01
Target: $255
- 02
Posted price: $223.24
- 03
Analyst firm: KeyBanc
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.